Methods and systems for predicting response of cells to a therapeutic agent

Details for Australian Patent Application No. 2009281721 (hide)

Owner Merrimack Pharmaceuticals, Inc.

Inventors Schoeberl, Birgit; Harms, Brian; Gibbons, Francis David; Fitzgerald, Jonathan Basil; Onsum, Matthew David; Nielsen, Ulrik; Kubasek, William

Agent Shelston IP

Pub. Number AU-A-2009281721

PCT Pub. Number WO2010/019952

Priority 61/208,206 20.02.09 US; 61/189,053 15.08.08 US; 61/170,367 17.04.09 US; 61/194,702 30.09.08 US

Filing date 17 August 2009

Wipo publication date 18 February 2010

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C07K 16/32 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

24 February 2011 PCT application entered the National Phase

  PCT publication WO2010/019952 Priority application(s): WO2010/019952

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009281723-Purine nucleoside phosphorylase as enzymatic activator of nucleoside prodrugs

2009281715-Foot stretcher used in conjunction with a rowing vessel or a mechanical rowing apparatus